The latest emerging drugs for the treatment of diabetic cardiomyopathy
Minghao Li,Lin Liu,Chunyu Zhang,Li Deng,Yi Zhong,Bin Liao,Xiuying Li,Ying Wan,Jian Feng
DOI: https://doi.org/10.1080/14656566.2024.2347468
2024-05-01
Expert Opinion on Pharmacotherapy
Abstract:Introduction Diabetic cardiomyopathy (DCM) is a serious complication of diabetes mellitus involving multiple pathophysiologic mechanisms. In addition to hypoglycemic agents commonly used in diabetes, metabolism-related drugs, natural plant extracts, melatonin, exosomes, and rennin-angiotensin-aldosterone system are cardioprotective in DCM. However, there is a lack of systematic summarization of drugs for DCM.
pharmacology & pharmacy
What problem does this paper attempt to address?